While there has been some evidence for increased arginase expression in airways of smokers with asthma [25] and COPD [26] and altered inducible NO synthase expression in COPD [26], a clear picture of the l-arginine metabolism in the COPD airways remains to be elucidated. This evidence concerns the gene NOS2 and chronic obstructive pulmonary disease.